{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:48:27Z","timestamp":1792788507437,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12882-017-0752-x","type":"journal-article","created":{"date-parts":[[2017,11,25]],"date-time":"2017-11-25T03:35:00Z","timestamp":1511580900000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Residual renal function in chronic dialysis is not associated with reduced erythropoietin-stimulating agent dose requirements: a cross-sectional study"],"prefix":"10.1186","volume":"18","author":[{"given":"Elizabeth Helene","family":"Louw","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9801-1300","authenticated-orcid":false,"given":"Mogamat-Yazied","family":"Chothia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,25]]},"reference":[{"issue":"9","key":"752_CR1","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1185\/030079904X2763","volume":"20","author":"W McClellan","year":"2004","unstructured":"McClellan W, Aronoff SL, Bolton WK, Hood S, Lorber DL, Tang KL, Tse TF, Wasserman B, Leiserowitz M. The prevalence of anemia in patients with chronic kidney disease. Curr Med Res Opin. 2004;20(9):1501\u201310.","journal-title":"Curr Med Res Opin"},{"issue":"5","key":"752_CR2","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/S0272-6386(04)01086-8","volume":"44","author":"Y Zhang","year":"2004","unstructured":"Zhang Y, Thamer M, Stefanik K, Kaufman J, Cotter DJ. Epoetin requirements predict mortality in hemodialysis patients. Am J Kidney Dis. 2004;44(5):866\u201376.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"752_CR3","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1080\/0886022X.2016.1244079","volume":"39","author":"W Wang","year":"2017","unstructured":"Wang W, Zhang W, Sun T, Ma F, Su S, Xu Z. Effect of peritoneal dialysis versus hemodialysis on renal anemia in renal in end-stage disease patients: a meta-analysis. Ren Fail. 2017;39(1):59\u201366.","journal-title":"Ren Fail"},{"issue":"2","key":"752_CR4","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1159\/000335685","volume":"35","author":"U Duong","year":"2012","unstructured":"Duong U, Kalantar-Zadeh K, Molnar MZ, Zaritsky JJ, Teitelbaum I, Kovesdy CP, Mehrotra R. Mortality associated with dose response of erythropoiesis-stimulating agents in hemodialysis versus peritoneal dialysis patients. Am J Nephrol. 2012;35(2):198\u2013208.","journal-title":"Am J Nephrol"},{"issue":"11","key":"752_CR5","doi-asserted-by":"crossref","first-page":"e0143348","DOI":"10.1371\/journal.pone.0143348","volume":"10","author":"MN Bae","year":"2015","unstructured":"Bae MN, Kim SH, Kim YO, Jin DC, Song HC, Choi EJ, Kim Y, Kim Y, Kang S, Kim N. Association of erythropoietin-stimulating agent responsiveness with mortality in hemodialysis and peritoneal dialysis patients. PLoS One. 2015;10(11):e0143348.","journal-title":"PLoS One"},{"issue":"1","key":"752_CR6","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/01.ASN.0000102475.94185.54","volume":"15","author":"JJ Snyder","year":"2004","unstructured":"Snyder JJ, Foley RN, Gilbertson DT, Vonesh EF, Collins AJ. Hemoglobin levels and erythropoietin doses in hemodialysis and peritoneal dialysis patients in the United States. J Am Soc Nephrol. 2004;15(1):174\u20139.","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"752_CR7","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1440-1797.2007.00810.x","volume":"12","author":"DW Johnson","year":"2007","unstructured":"Johnson DW, Pollock CA, Macdougall IC. Erythropoiesis-stimulating agent hyporesponsiveness (review article). Nephrology. 2007;12(4):321\u201330.","journal-title":"Nephrology"},{"issue":"1","key":"752_CR8","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1471-2369-14-44","volume":"14","author":"DT Gilbertson","year":"2013","unstructured":"Gilbertson DT, Peng Y, Arneson TJ, Dunning S, Collins AJ. Comparison of methodologies to define hemodialysis patients hyporesponsive to epoetin and impact on counts and characteristics. BMC Nephrol. 2013;14(1):44.","journal-title":"BMC Nephrol"},{"issue":"10","key":"752_CR9","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1681\/ASN.V12102158","volume":"12","author":"JM Bargman","year":"2001","unstructured":"Bargman JM, Thorpe KE, Churchill DN, CANUSA Peritoneal Dialysis Study Group. Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study. J Am Soc Nephrol. 2001;12(10):2158\u201362.","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"752_CR10","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0272-6386(03)00362-7","volume":"41","author":"F Termorshuizen","year":"2003","unstructured":"Termorshuizen F, Korevaar JC, Dekker FW, van Manen JG, Boeschoten EW, Krediet RT, NECOSAD Study Group. The relative importance of residual renal function compared with peritoneal clearance for patient survival and quality of life: an analysis of the Netherlands cooperative study on the adequacy of dialysis (NECOSAD)-2. Am J Kidney Dis. 2003;41(6):1293\u2013302.","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"752_CR11","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1681\/ASN.V1351307","volume":"13","author":"R Paniagua","year":"2002","unstructured":"Paniagua R, Amato D, Vonesh E, Correa-Rotter R, Ramos A, Moran J, Mujais S, Mexican Nephrology Collaborative Study Group. Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol. 2002;13(5):1307\u201320.","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"752_CR12","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1046\/j.1523-1755.2002.00505.x","volume":"62","author":"MA Jansen","year":"2002","unstructured":"Jansen MA, Hart AA, Korevaar JC, Dekker FW, Boeschoten EW, Krediet RT. Predictors of the rate of decline of residual renal function in incident dialysis patients. Kidney Int. 2002;62(3):1046\u201353.","journal-title":"Kidney Int"},{"issue":"3","key":"752_CR13","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/hdi.12407","volume":"20","author":"Y Chait","year":"2016","unstructured":"Chait Y, Kalim S, Horowitz J, Hollot CV, Ankers ED, Germain MJ, Thadhani RI. The greatly misunderstood erythropoietin resistance index and the case for a new responsiveness measure. Hemodial Int. 2016;20(3):392\u20138.","journal-title":"Hemodial Int"},{"issue":"3","key":"752_CR14","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1109\/TBME.2013.2286100","volume":"61","author":"Y Chait","year":"2014","unstructured":"Chait Y, Horowitz J, Nichols B, Shrestha RP, Hollot CV, Germain MJ. Control-relevant erythropoiesis modeling in end-stage renal disease. IEEE Trans Biomed Eng. 2014;61(3):658\u201364.","journal-title":"IEEE Trans Biomed Eng"},{"issue":"2","key":"752_CR15","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2215\/CJN.04480510","volume":"6","author":"EL Penne","year":"2011","unstructured":"Penne EL, van der Weerd NC, Grooteman MP, Mazairac AH, van den Dorpel MA, Nube MJ, Bots ML, Levesque R, ter Wee PM, Blankestijn PJ, CONTRAST investigators. Role of residual renal function in phosphate control and anemia management in chronic hemodialysis patients. Clin J Am Soc Nephrol. 2011;6(2):281\u20139.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"752_CR16","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1053\/j.ajkd.2010.03.020","volume":"56","author":"T Shafi","year":"2010","unstructured":"Shafi T, Jaar BG, Plantinga LC, Fink NE, Sadler JH, Parekh RS, Powe NR, Coresh J. Association of residual urine output with mortality, quality of life, and inflammation in incident hemodialysis patients: the choices for healthy outcomes in caring for end-stage renal disease (CHOICE) study. Am J Kidney Dis. 2010;56(2):348\u201358.","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"752_CR17","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1774-9987.2005.00260.x","volume":"9","author":"J Pajek","year":"2005","unstructured":"Pajek J, Bu\u010dar-Pajek M, Grego K, Gu\u010dek A, Bevc S, Ekart R, Vujkovac B, Golob-Kosmina P, Kandus A, Bren AF. Epoetin responsiveness in peritoneal dialysis patients: a multi-center Slovenian study. Ther Apher Dial. 2005;9(3):228\u201332.","journal-title":"Ther Apher Dial"},{"issue":"Suppl 1","key":"752_CR18","first-page":"41","volume":"132","author":"MN SJ","year":"2016","unstructured":"SJ MN, Casula A, Shaw C, Castledine C. UK renal registry 18th annual report: chapter 2 UK renal replacement therapy prevalence in 2014: national and Centre-specific analyses. Nephron. 2016;132(Suppl 1):41\u201368.","journal-title":"Nephron"},{"issue":"(2016)(13)","key":"752_CR19","doi-asserted-by":"crossref","first-page":"18","DOI":"10.5414\/CNP86S128","volume":"86","author":"EL Bamgboye","year":"2016","unstructured":"Bamgboye EL. The challenges of ESRD care in developing economies: sub-Saharan African opportunities for significant improvement. Clin Nephrol. 2016;86((2016)(13)):18\u201322.","journal-title":"Clin Nephrol"},{"issue":"10","key":"752_CR20","first-page":"470","volume":"64","author":"M Nadeem","year":"2009","unstructured":"Nadeem M, Stephen L, Schubert C, Davids M. Association between periodontitis and systemic inflammation in patients with end-stage renal disease. S Afr Dent J. 2009;64(10):470\u20133.","journal-title":"S Afr Dent J"},{"issue":"3","key":"752_CR21","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1681\/ASN.V113556","volume":"11","author":"LM Moist","year":"2000","unstructured":"Moist LM, Port FK, Orzol SM, Young EW, Ostbye T, Wolfe RA, Hulbert-Shearon T, Jones CA, Bloembergen WE. Predictors of loss of residual renal function among new dialysis patients. J Am Soc Nephrol. 2000;11(3):556\u201364.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"752_CR22","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3747\/pdi.2009.00088","volume":"31","author":"I Kolesnyk","year":"2011","unstructured":"Kolesnyk I, Noordzij M, Dekker FW, Boeschoten EW, Krediet RT. Treatment with angiotensin II inhibitors and residual renal function in peritoneal dialysis patients. Perit Dial Int. 2011;31(1):53\u20139.","journal-title":"Perit Dial Int"},{"issue":"Pt 2","key":"752_CR23","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1042\/bj2960373","volume":"296","author":"KJ Rieger","year":"1993","unstructured":"Rieger KJ, Saez-Servent N, Papet MP, Wdzieczak-Bakala J, Morgat JL, Thierry J, Voelter W, Lenfant M. Involvement of human plasma angiotensin I-converting enzyme in the degradation of the haemoregulatory peptide N-acetyl-seryl-aspartyl-lysyl-proline. Biochem J. 1993;296(Pt 2):373\u20138.","journal-title":"Biochem J"},{"issue":"3","key":"752_CR24","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1053\/ajkd.2001.26839","volume":"38","author":"Y Le Meur","year":"2001","unstructured":"Le Meur Y, Lorgeot V, Comte L, Szelag J, Aldigier J, Leroux-Robert C, Praloran V. Plasma levels and metabolism of AcSDKP in patients with chronic renal failure: relationship with erythropoietin requirements. Am J Kidney Dis. 2001;38(3):510\u20137.","journal-title":"Am J Kidney Dis"},{"issue":"8","key":"752_CR25","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1093\/ndt\/14.8.1836","volume":"14","author":"IC Macdougall","year":"1999","unstructured":"Macdougall IC. The role of ACE inhibitors and angiotensin II receptor blockers in the response to epoetin. Nephrol Dial Transplant. 1999;14(8):1836\u201341.","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"752_CR26","first-page":"91","volume":"19","author":"P Saudan","year":"2006","unstructured":"Saudan P, Halabi G, Perneger T, Wasserfallen J, Wauters J, Martin P, Western Switzerland Dialysis G. ACE inhibitors or angiotensin II receptor blockers in dialysed patients and erythropoietin resistance. J Nephrol. 2006;19(1):91.","journal-title":"J Nephrol"},{"issue":"3","key":"752_CR27","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1053\/j.ajkd.2009.12.042","volume":"56","author":"DV Vlahakos","year":"2010","unstructured":"Vlahakos DV, Marathias KP, Madias NE. The role of the renin-angiotensin system in the regulation of erythropoiesis. Am J Kidney Dis. 2010;56(3):558\u201365.","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"752_CR28","doi-asserted-by":"crossref","first-page":"483","DOI":"10.2174\/1568026043451311","volume":"4","author":"K Marathias","year":"2004","unstructured":"Marathias K, Agroyannis B, Mavromoustakos T, Matsoukas J, Vlahakos D. Hematocrit-lowering effect following inactivation of renin-angiotensin system with angiotensin converting enzyme inhibitors and angiotensin receptor blockers. Curr Top Med Chem. 2004;4(4):483\u20136.","journal-title":"Curr Top Med Chem"},{"issue":"8","key":"752_CR29","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/ajh.23255","volume":"87","author":"A Shah","year":"2012","unstructured":"Shah A, Molnar MZ, Lukowsky LR, Zaritsky JJ, Kovesdy CP, Kalantar-Zadeh K. Hemoglobin level and survival in hemodialysis patients with polycystic kidney disease and the role of administered erythropoietin. Am J Hematol. 2012;87(8):833\u20136.","journal-title":"Am J Hematol"},{"issue":"6","key":"752_CR30","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.surg.2008.07.026","volume":"144","author":"JA Trunzo","year":"2008","unstructured":"Trunzo JA, McHenry CR, Schulak JA, Wilhelm SM. Effect of parathyroidectomy on anemia and erythropoietin dosing in end-stage renal disease patients with hyperparathyroidism. Surgery. 2008;144(6):915\u20139.","journal-title":"Surgery"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-017-0752-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,8]],"date-time":"2022-08-08T17:15:20Z","timestamp":1659978920000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-017-0752-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,25]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["752"],"URL":"https:\/\/doi.org\/10.1186\/s12882-017-0752-x","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,25]]},"article-number":"336"}}